Composition:
-Each film coated tablet of Atorvazal40 contains: Atorvastatin 40 mg (as Atorvastatin Calcium Trihydrate).
Pharmacotherapeutic group:
Lipid modifying agents, HMG-CoA-reductase inhibitor.
Indications:
Atorvazal is indicated as an adjunct to diet for:
-Primary hypercholestrolaemia.
-Heterozygous familial hypercholestrolaemia.
-Homozygous familial hypercholestrolaemia or combined mixed hyperlipidaemia in patients who have not responded adequately to diet and other appropriate measures.
-Prevention of cardiovascular events in patients with type 2 diabetes and at least one additional factor for cardiovascular disease.
Dosage and administration:
-The patient should be placed on standard cholesterol lowering diet before receiving
Atorvazal and should continue on this diet during treatment with Atorvazal.
-Dosage should be individualized according to baseline LDL-C levels, the goal of therapy, and the patient response.
-Each dose of Atorvazal is given once a day and may be given at any time of day with or without food.
-10 mg of Atorvazal once a day should be prescribed as a usual starting dose for treatment of:
-Primary hypercholestrolaemia, heterozygous familial hypercholestrolaemia, homozygous familial hypercholestrolaemia or (combined mixed) hyperlipidaemia and prevention of cardiovascular events in patients with type 2 diabetes.
-Adjustment of dose should be made at intervals of 4 weeks or more.
-The maximum dose is 80 mg once a day.
-Pediatric use should only be carried out by specialist; the recommended starting dose in this population is 10 mg of Atorvazal /day.
-The dose may be increased to 20 mg / day according to the response and tolerability.
